Baike biological disclosure 2022 semi -annual report achieved revenue of 441 million yuan

On August 25, the A -share listed company a hundred grams of biology (code: 688276.SH) released the 2022 semi -annual performance report.

From January 1, 2022-June 30, 2022, the company realized operating income of 441 million yuan, a year-on-year decrease of 24.28%, and net profit was 73.5717 million yuan, a year-on-year decrease of 46.83%, and the basic earnings per share were 0.18 yuan.

The company's industry is biological products.

During the company's reporting period, the total assets at the end of the period were 41.63 billion yuan, operating profit was 80.437 million yuan, and the accounts receivable were 759 million yuan. The net cash flow generated by operating activities was -26.335 million yuan.The cash was 384 million yuan.

Bio biology, the company's full name is Changchun 100g Biotechnology Co., Ltd., established on March 04, 2004. The current general manager Kong Wei, the main business is the research and development, production and sales of vaccines for people.

- END -